Table 1.

Data domain, measures, and clinic visit time points extracted from EHR^a.

Domain and measure (target value and description)b		Collection time points
Medications, prescriptions, and refills
	PDCc glucose-lowering agents	Date of first dispensing the medication in 2018 to the last dispensing in 2021
	PDC lipid-lowering agents	Date of first dispensing the medication in 2018 to the last dispensing in 2021
	PDC antihypertensive agents	Date of first dispensing the medication in 2018 to the last dispensing in 2021
C-MCId
	HbA1ce (≤7%)	All visits in measurement period
	LDL-Cf (<100 mg/dL)	All visits in measurement period
	SBPg (<130 mm Hg)	All visits in measurement period
Patient demographics
	Age (date of birth)	As of January 1, 2018
	Sex (male or female)	As of January 1, 2018
	Community of residence (coded)	As of January 1, 2018
Comorbid conditions
	CVDh, CKDi, and obesity with BMI (≥30)	As of January 1, 2018
Common laboratory tests
	eGFRj, lipid panel, CMPk, HbA1c, and CBCl	All visits in measurement period

^aEHR: electronic health record.

^bValues will be collected from patients aged ≥18 years with type 2 diabetes (based on the International Classification of Diseases, Tenth Revision code).

^cPDC: proportion of days covered.

^dC-MCI: cardiometabolic control indicators.

^eHbA1c: hemoglobin A1c values defined according to the American College of Physicians guidelines for 2018.

^fLDL-C: low-density lipoprotein cholesterol values defined according to the American College of Physicians guidelines for 2018.

^gSBP: systolic blood pressure values defined according to the American College of Physicians guidelines for 2018.

^hCVD: cardiovascular disease.

ⁱCKD: chronic kidney disease.

^jeGFR: estimated glomerular filtration rate.

^kCMP: comprehensive metabolic panel.

^lCBC: complete blood count.